GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SINTX Technologies Inc (FRA:1110) » Definitions » EPS (Diluted)

SINTX Technologies (FRA:1110) EPS (Diluted) : €-415.64 (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is SINTX Technologies EPS (Diluted)?

SINTX Technologies's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-20.24. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-415.64.

SINTX Technologies's EPS (Basic) for the three months ended in Mar. 2024 was €-9.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was €-361.43.

SINTX Technologies's EPS without NRI for the three months ended in Mar. 2024 was €-32.46. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was €-497.56.

During the past 3 years, the average EPS without NRIGrowth Rate was 63.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, SINTX Technologies's highest 3-Year average EPS without NRI Growth Rate was 91.50% per year. The lowest was -201.90% per year. And the median was 7.20% per year.


SINTX Technologies EPS (Diluted) Historical Data

The historical data trend for SINTX Technologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SINTX Technologies EPS (Diluted) Chart

SINTX Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -65,796.66 -12,653.54 -7,064.07 -11,480.93 -574.04

SINTX Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -325.03 -143.99 -151.79 -99.62 -20.24

Competitive Comparison of SINTX Technologies's EPS (Diluted)

For the Medical Devices subindustry, SINTX Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SINTX Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's PE Ratio falls into.



SINTX Technologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

SINTX Technologies's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.574-0.024)/0.022
=-345.36

SINTX Technologies's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.815-0)/0.172
=-4.74

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-415.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SINTX Technologies  (FRA:1110) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


SINTX Technologies EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of SINTX Technologies's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


SINTX Technologies (FRA:1110) Business Description

Traded in Other Exchanges
Address
1885 West 2100 South, Salt Lake City, UT, USA, 84119
SINTX Technologies Inc is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture, and sell a range of medical devices. The company derives product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. It produces silicon nitride for use in commercial products and product candidates in the forms of Solid Silicon Nitride, Porous Silicon Nitride, and Silicon Nitride Powder, among others. It is also engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty.

SINTX Technologies (FRA:1110) Headlines

No Headlines